Follow
Gilbert Burckart
Gilbert Burckart
Verified email at fda.hhs.gov
Title
Cited by
Cited by
Year
Clinical pharmacokinetics of tacrolimus
R Venkataramanan, A Swaminathan, T Prasad, A Jain, S Zuckerman, ...
Clinical pharmacokinetics 29, 404-430, 1995
9761995
Nuclear factor kappa B: important transcription factor and therapeutic target
JI Lee, GJ Burckart
The Journal of clinical pharmacology 38 (11), 981-993, 1998
6161998
Clinical pharmacokinetics of cyclosporin
RJ Ptachcinski, R Venkataramanan, GJ Burckart
Clinical pharmacokinetics 11, 107-132, 1986
5361986
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process
SM Huang, JM Strong, L Zhang, KS Reynolds, S Nallani, R Temple, ...
The Journal of clinical pharmacology 48 (6), 662-670, 2008
4242008
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms
HX Zheng, S Webber, A Zeevi, E Schuetz, J Zhang, P Bowman, G Boyle, ...
American Journal of Transplantation 3 (4), 477-483, 2003
3462003
Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use
FW Frueh, S Amur, P Mummaneni, RS Epstein, RE Aubert, TM DeLuca, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (8 …, 2008
3382008
Extrapolation of adult data and other data in pediatric drug-development programs
J Dunne, WJ Rodriguez, MD Murphy, BN Beasley, GJ Burckart, JD Filie, ...
Pediatrics 128 (5), e1242-e1249, 2011
3182011
A randomized trial of inhaled cyclosporine in lung-transplant recipients
AT Iacono, BA Johnson, WF Grgurich, JG Youssef, TE Corcoran, ...
New England Journal of Medicine 354 (2), 141-150, 2006
2622006
Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism
HX Zheng, A Zeevi, E Schuetz, J Lamba, K McCurry, BP Griffith, S Webber, ...
The Journal of Clinical Pharmacology 44 (2), 135-140, 2004
1962004
Tacrolimus: a new immunosuppressive agent
PA Kelly, GJ Burckart, R Venkataramanan
American journal of health-system pharmacy 52 (14), 1521-1535, 1995
1951995
HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction
AL Girnita, R Duquesnoy, SA Yousem, AT Iacono, TE Corcoran, ...
American journal of transplantation 5 (1), 131-138, 2005
1922005
Regulatory experience with physiologically based pharmacokinetic modeling for pediatric drug trials
R Leong, MLT Vieira, P Zhao, Y Mulugeta, CS Lee, SM Huang, ...
Clinical Pharmacology & Therapeutics 91 (5), 926-931, 2012
1882012
A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.
SR Duncan, WF Grgurich, AT Iacono, GJ Burckart, SA Yousem, IL Paradis, ...
American journal of respiratory and critical care medicine 150 (1), 146-152, 1994
1881994
CYCLOSPORINE A INHIBITS THE EXPRESSION OF COSTIMULATORY MOLECULES ON IN VITRO-GENERATED DENDRITIC CELLS: Association with Reduced Nuclear Translocation of Nuclear Factor Kappa B: 1
JI Lee, RW Ganster, DA Geller, GJ Burckart, AW Thomson, L Lu
Transplantation 68 (9), 1255-1263, 1999
1831999
Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure
JA Carcillo, L Doughty, D Kofos, RF Frye, SS Kaplan, H Sasser, ...
Intensive care medicine 29, 980-984, 2003
1822003
Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome
HR Wong, JA Carcillo, G Burckart, N Shah, JE Janosky
Critical care medicine 23 (5), 835-842, 1995
1701995
Aerosolized cyclosporine in lung recipients with refractory chronic rejection.
AT Iacono, RJ Keenan, SR Duncan, GC Smaldone, JH Dauber, IL Paradis, ...
American journal of respiratory and critical care medicine 153 (4), 1451-1455, 1996
1671996
HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection
AL Girnita, KR McCurry, AT Iacono, R Duquesnoy, TE Corcoran, M Awad, ...
The Journal of heart and lung transplantation 23 (10), 1135-1141, 2004
1602004
P‐glycoprotein and drug therapy in organ transplantation
A Lo, GJ Burckart
The Journal of Clinical Pharmacology 39 (10), 995-1005, 1999
1591999
Assessment of the impact of renal impairment on systemic exposure of new molecular entities: evaluation of recent new drug applications
Y Zhang, L Zhang, S Abraham, S Apparaju, TC Wu, JM Strong, S Xiao, ...
Clinical Pharmacology & Therapeutics 85 (3), 305-311, 2009
1562009
The system can't perform the operation now. Try again later.
Articles 1–20